Senate passes legislation to ensure no halt in FDA reviews
Share
Tweet
August 4, 2017
WASHINGTON (AP) — Drug and medical device makers would pay higher user fees under legislation the Senate approved and sent to the president on Thursday. The revenue raised would help pay for the government reviews required to bring their products to the market.
Senate Majority Leader Mitch McConnell, R-Ky., said the bill's passage will ensure the review of medical devices and medicine won't come to a screeching halt in a few weeks. The current law governing these fees expires Sept. 30.
The legislation cleared the Senate on a vote of 94-1. The bill also includes measures to help an array of pat...
For access to this article please
sign in or
subscribe.
Reader Comments(0)